Axon Enterprise Inc

RSS Feed
Axon Enterprise is provider of law enforcement technology solutions. The company's operations are comprised of two reportable segments: TASER, which is focused on development, manufacture and sale of conducted energy weapons, also known as conducted energy devices, which the company sells under its brand name, TASER; and software and sensors, which is focused on-officer body (Axon Body and Flex) and in-car (Axon Fleet) cameras as well as cloud-based digital evidence management software (Evidence.com), as well as develops, manufactures and sells hardware and cloud-based software solutions that enable law enforcement to capture, store, manage, share and analyze video and other digital evidence.
  • TickerAAXN
  • ISINUS05464C1018
  • ExchangeNASDAQ Stock Market
  • SectorAerospace & Defense
  • CountryUnited States
Vermilion Research
Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

EUR 41.44
Equity
Personal & Household Goods
GOLF , ALRM ...
69d 09/11/2020 31 EN
Vermilion Research
Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: The Consumer Discretionary Sector continues to have several names as leadership. (ex. NWHM, DLA, DDS, DLTH, LAZY, and BGFV) Biotechnology has several leadership names. (ex. ALDX, CRSP, ANAB, NTLA, IMGN, DCPH, RAPT, IOVA, CBAY, EIDX, RTRX, CLPT, KALV, and SAGE)

EUR 41.44
Equity
Health Care
ALDX , FPRP ...
90d 19/10/2020 22 EN
Vermilion Research
Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

EUR 41.44
Equity
Industrial Goods & Services
AMN , AVYA ...
93d 16/10/2020 1 EN
Vermilion Research
Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

EUR 41.44
Equity
Retail
ANF , ADNT ...
107d 02/10/2020 24 EN
TheScreener

AXON ENTERPRISE receives two new qualifications and slightly improves to Neutral

The independent financial analyst theScreener just changed two ratings for the qualification of AXON ENTERPRISE (US), active in the Aerospace & Defense industry. Its market behaviour has improved and can now be considered as moderately risky; its fundamental valuation receives an improved star rating and now shows 3 out of 4 stars. theScreener considers that these elements slightly improve the general evaluation, which passes therefore to Neutral. As of the analysis date September 29, 2020, the closing price was USD 88.62 and its expected value was estimated at USD 86.14.

EUR 12.43
Quant
Industrial Goods & Services
Axon Enterprise Inc
110d 30/09/2020 6 EN
Vermilion Research
Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

EUR 41.44
Chart
Technology
AGYS , APD ...
350d 02/02/2020 25 EN
Vermilion Research
Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

• A number of Consumer Cyclical names continue to indicate leadership. (ex. THO, WGO, CROX, WLH, LEN, KBH, PZZA, TXRH, SCVL, GCO, and RH) • The Healthcare Sector has a number of attractive names developing major bases and staging RS reversals. (ex. CAH, HSIC, ITGR, ABT, MLAB, RMD, SYK, MD, RDNT, TRHC, CNC, WCG, RGNX, BEO, and SYNH) • The Technology Sector continues to be long-term leadership. Many issues are extended and we would suggest taking opportunity of any weakness. (ex. TER, AMAT, SYNA, INTC, AVGO, INTU, LPSN, CTXS, ADP, EXLS, PRSP, and FN)

EUR 41.44
Chart
Health Care
ABT , ALLE ...
1y 27/01/2020 26 EN
Vermilion Research
Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of significant Communications names are developing bullishly. (ex. GOOG, FB, and NWS) • Consumer Discretionary names continue to develop positively. (ex. THRM, LEA, WYNN, PENN, CMG, KMX, and AMZN) • Energy Sector names continue to attempt to carve out bottoms. (ex. OXY, VAL) • Financial Sector names continue to develop bullishly (ex. C, UMPQ, EWBC, TROW, MSCI, SPGI, GS, and MS)

EUR 41.44
Chart
Technology
AMD , GOOG ...
1y 06/01/2020 24 EN
Vermilion Research
Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

EUR 41.44
Chart
Retail
ATGE , AGIO ...
1y 01/11/2019 1 EN
Vermilion Research
Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

EUR 41.44
Chart
Telecommunications
EGHT , ADBE ...
1y 21/10/2019 22 EN
BusinessWire

Zamansky LLC Investigates Axon Enterprise (NASDAQ: AAXN) for Potential Breaches of Fiduciary Duties to Shareholders

NEW YORK--(BUSINESS WIRE)-- Zamansky LLC announces that it is investigating Axon Enterprise Inc. (NASDAQ:AAXN) (“Axon”) for potential breaches of fiduciary duties to shareholders. Axon, formerly known as Taser International, is a manufacturer of electrical weapons and body cameras which it sells to local law enforcement departments. If you are a shareholder of Axon, please contact our firm for information. On October 19, 2017, Axon disclosed that it had received a letter of inquiry from the SEC relating to the review of its a...

Free
Corporate Voice
Industrial Goods & Services
Axon Enterprise Inc
2y 02/03/2018 1 EN
BusinessWire

Zamansky LLC Investigates Axon Enterprises (AAXN) for Potential Breaches of Fiduciary Duties to Shareholders

NEW YORK--(BUSINESS WIRE)-- Zamansky LLC announces that it is investigating Axon Enterprises Inc. (AAXN) for potential breaches of fiduciary duties to shareholders. Axon, which was formerly named Taser International, is a manufacturer of electrical weapons and body cameras which it sells to local law enforcement departments. If you are a shareholder of Axon, please contact our firm for information. On October 19, 2017, Axon disclosed that it had received a letter of inquiry from the SEC relating to the review of its annual an...

Free
Corporate Voice
Industrial Goods & Services
Axon Enterprise Inc
3y 10/11/2017 1 EN
BusinessWire

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Axon Enterprise, Inc.

NEW YORK--(BUSINESS WIRE)-- Levi & Korsinsky announces it has commenced an investigation of Axon Enterprise, Inc. (“Axon” or the “Company”) (NASDAQ: AAXN) concerning possible violations of federal securities laws. On October 19, 2017, Axon announced it “became aware of a comment letter issued by the Securities and Exchange Commission (“SEC”) relating to the SEC’s review of the Company’s 10-K for the year ended December 31, 2016 and Form 10-Q for the quarter ended March 31, 2017.” Axon stated that “miscommunication issues” cau...

Free
Corporate Voice
Industrial Goods & Services
Axon Enterprise Inc
3y 24/10/2017 1 EN
BusinessWire

SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Axon Enterprise, Inc.

LOS ANGELES--(BUSINESS WIRE)-- Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Axon Enterprise, Inc. (“Axon” or the “Company”) (Nasdaq: AAXN). If you purchased or otherwise acquired Axon shares, and would like more information about the investigation, we encourage you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars, Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your right...

Free
Corporate Voice
Industrial Goods & Services
Axon Enterprise Inc
3y 23/10/2017 1 EN
BusinessWire

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Axon Enterprise, Inc.

NEW YORK--(BUSINESS WIRE)-- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of investors of Axon Enterprise, Inc. (“Axon”) (NASDAQ:AAXN) resulting from allegations that Axon may have issued materially misleading business information to the investing public. On October 19, 2017, Axon announced during aftermarket hours that the U.S. Securities and Exchange Commission (“SEC”) is reviewing its financial statements. Specifically, the SEC issued three letters in...

Free
Corporate Voice
Industrial Goods & Services
Axon Enterprise Inc
3y 23/10/2017 1 EN
Vermilion Research
Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

EUR 41.44
Equity
Personal & Household Goods
GOLF , ALRM ...
69d 09/11/2020 31 EN
Vermilion Research
Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: The Consumer Discretionary Sector continues to have several names as leadership. (ex. NWHM, DLA, DDS, DLTH, LAZY, and BGFV) Biotechnology has several leadership names. (ex. ALDX, CRSP, ANAB, NTLA, IMGN, DCPH, RAPT, IOVA, CBAY, EIDX, RTRX, CLPT, KALV, and SAGE)

EUR 41.44
Equity
Health Care
ALDX , FPRP ...
90d 19/10/2020 22 EN
Vermilion Research
Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

EUR 41.44
Equity
Industrial Goods & Services
AMN , AVYA ...
93d 16/10/2020 1 EN
Vermilion Research
Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

EUR 41.44
Equity
Retail
ANF , ADNT ...
107d 02/10/2020 24 EN
Vermilion Research
Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

EUR 41.44
Equity
Personal & Household Goods
ATVI , AAXN ...
202d 29/06/2020 21 EN
TheScreener

AXON ENTERPRISE receives two new qualifications and slightly improves to Neutral

The independent financial analyst theScreener just changed two ratings for the qualification of AXON ENTERPRISE (US), active in the Aerospace & Defense industry. Its market behaviour has improved and can now be considered as moderately risky; its fundamental valuation receives an improved star rating and now shows 3 out of 4 stars. theScreener considers that these elements slightly improve the general evaluation, which passes therefore to Neutral. As of the analysis date September 29, 2020, the closing price was USD 88.62 and its expected value was estimated at USD 86.14.

EUR 12.43
Quant
Industrial Goods & Services
Axon Enterprise Inc
110d 30/09/2020 6 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch